Comparison of PCR-based detection of chromogranin A mRNA with traditional histological lymph node staging of small intestinal neuroendocrine neoplasia

被引:3
作者
Lawrence B. [1 ]
Kenney B. [2 ]
Svejda B. [1 ]
Schimmack S. [1 ]
Alaimo D. [1 ]
Barbieri A. [2 ]
Jedrych J. [2 ]
Kidd M. [1 ]
Modlin I. [1 ]
机构
[1] Gastrointestinal Pathobiology Research Group, Yale University, School of Medicine, New Haven
[2] Department of Pathology, Division of Gastrointestinal and Hepatic Pathology, Yale University School of Medicine, New Haven
基金
美国国家卫生研究院;
关键词
Chromogranin A; Histopathology; Immunohistochemistry; Lymph node; Metastasis; Micrometastasis; Neuroendocrine neoplasm; Neuroendocrine tumor; RNA; Staging;
D O I
10.1186/1756-0500-5-318
中图分类号
学科分类号
摘要
Background: Accurate neuroendocrine neoplasia (NEN) staging is vital for determining prognosis and therapeutic strategy. The great majority of NENs express chromogranin A (CgA) which can be detected at a protein or transcript level. The current standards for lymph node metastasis detection are histological examination after Hematoxylin and Eosin (H&E) and CgA immunohistochemical (IHC) staining. We hypothesized that detection of CgA mRNA transcripts would be a more sensitive method of detecting these metastases. Findings: We compared these traditional methods with PCR for CgA mRNA extracted from formalin fixed paraffin embedded slides of lymph nodes (n = 196) from small intestinal NENs, other gastrointestinal cancers and benign gastrointestinal disease. CgA PCR detected significantly more NEN lymph nodes (75%) than H&E (53%) or CgA IHC (57%) (p = 0.02). PCR detected CgA mRNA in 50% (14 of the 28) of SI-NEN lymph nodes previously considered negative. The false positive rate for detection of CgA mRNA was 19% in non-neuroendocrine cancers, and appeared to be due to occult neuroendocrine differentiation or contamination by normal epithelium during histological processing. Conclusions: Molecular pathological analysis demonstrates the limitations of observer-dependent histopathology. CgA PCR analysis detected the presence of CgA transcripts in lymph nodes without histological evidence of tumor metastasis. Molecular node positivity (stage molN1) of SI-NEN lymph nodes could confer greater staging accuracy and facilitate early and accurate therapeutic intervention. This technique warrants investigation using clinically annotated tumor samples with follow-up data. © 2012 Lawrence et al.; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 16 条
[1]  
Qiu Y., Yang H., Chen H., Ge L., Xu X., Xiong X., He J., Detection of CEA mRNA, p53 and AE1/AE3 in haematoxylin-eosin-negative lymph nodes of early-stage non-small cell lung cancer may improve veracity of N staging and indicate prognosis, Jpn J Clin Oncol, 40, pp. 146-152, (2010)
[2]  
Sonoda H., Yamamoto K., Kushima R., Okabe H., Tani T., Detection of lymph node micrometastasis in gastric cancer by MUC2 RT-PCR: Usefulness in pT1 cases, Journal of Surgical Oncology, 88, 2, pp. 63-70, (2004)
[3]  
Soikkeli J., Lukk M., Nummela P., Virolainen S., Jahkola T., Katainen R., Harju L., Ukkonen E., Saksela O., Holtta E., Systematic search for the best gene expression markers for melanoma micrometastasis detection, Journal of Pathology, 213, 2, pp. 180-189, (2007)
[4]  
Shores C.G., Yin X., Funkhouser W., Yarbrough W., Clinical evaluation of a new molecular method for detection of micrometastases in head and neck squamous cell carcinoma, Archives of Otolaryngology - Head and Neck Surgery, 130, 8, pp. 937-942, (2004)
[5]  
Ho S.B., Hyslop A., Albrecht R., Jacobson A., Spencer M., Rothenberger D.A., Niehans G.A., D'Cunha J., Kratzke R.A., Quantification of colorectal cancer micrometastases in lymph nodes by nested and real-time reverse transcriptase-PCR analysis for carcinoembryonic antigen, Clinical Cancer Research, 10, 17, pp. 5777-5784, (2004)
[6]  
Kowalewska M., Radziszewski J., Kulik J., Barathova M., Nasierowska-Guttmajer A., Bidzinski M., Pastorek J., Pastorekova S., Siedlecki J.A., Detection of carbonic anhydrase 9-expressing tumor cells in the lymph nodes of vulvar carcinoma patients by RT-PCR, International Journal of Cancer, 116, 6, pp. 957-962, (2005)
[7]  
Viale G., Dell'Orto P., Biasi M.O., Stufano V., De Brito Lima L.N., Paganelli G., Maisonneuve P., Vargo J.M., Green G., Cao W., Comparative evaluation of an extensive histopathologic examination and a real-time reverse-transcription-polymerase chain reaction assay for mammaglobin and cytokeratin 19 on axillary sentinel lymph nodes of breast carcinoma patients, Ann Surg, 247, pp. 136-142, (2008)
[8]  
Kuo C.T., Hoon D.S.B., Takeuchi H., Turner R., Wang H.-J., Morton D.L., Taback B., Prediction of disease outcome in melanoma patients by molecular analysis of paraffin-embedded sentinel lymph nodes, Journal of Clinical Oncology, 21, 19, pp. 3566-3572, (2003)
[9]  
Mocellin S., Hoon D.S.B., Pilati P., Rossi C.R., Nitti D., Sentinel lymph node molecular ultrastaging in patients with melanoma: A systematic review and meta-analysis of prognosis, Journal of Clinical Oncology, 25, 12, pp. 1588-1595, (2007)
[10]  
Kidd M., Modlin I.M., Mane S.M., Camp R.L., Eick G., Latich I., The role of genetic markers - NAP1L1, MAGE-D2, and MTA1 - In defining small-intestinal carcinoid neoplasia, Annals of Surgical Oncology, 13, 2, pp. 253-262, (2006)